Amgen
Biotech pioneer founded 1980 — Enbrel, Prolia, and PCSK9 inhibitor Repatha; large-scale CHO cell culture manufacturing at Thousand Oaks and Puerto Rico sites.
- Country
- United States
- Revenue
- $33.4B
- Employees
- ~24,000 emp
FDA GMP
GMP EU
Coverage
| CN | EU | US | |
|---|---|---|---|
| therapeutics-platforms | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biologics | therapeutics-platforms | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.